Rahamat Unissa Syed, S Afsar, Nayla Ahmed Mohammed Aboshouk, Sadeem Salem Alanzi, Rania Abdeen Hussain Abdalla, Amna Abakar Suleiman Khalifa, Jerlyn Apatan Enrera, Nancy Mohammad Elafandy, Randa Abdeen Husien Abdalla, Omar Hafiz Haj Ali, G Satheesh Kumar, Maali D Alshammari
Necroptosis, a controlled type of cell death that is different from apoptosis, has become a key figure in the aetiology of cancer and offers a possible target for treatment. A growing number of biological activities, including necroptosis, have been linked to long noncoding RNAs (lncRNAs), a varied family of RNA molecules with limited capacity to code for proteins. The complex interactions between LncRNAs and important molecular effectors of necroptosis, including mixed lineage kinase domain-like pseudokinase (MLKL) and receptor-interacting protein kinase 3 (RIPK3), will be investigated...
March 5, 2024: Pathology, Research and Practice